Enveda: Dermatitis drug candidate could help treat asthma
Boulder-based Enveda Biosciences, which uses machine learning to discover naturally occurring drug compounds, plans to begin testing ENV-294, its leading drug candidate developed to treat atopic dermatitis, as a treatment for asthma.
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!
Related Posts
-
McKee Wellness Foundation’s Lifesaver Soiree raised $325,000 for the organization’s Next Frontier initiative, a slate…
-
InnerTrek, an Oregon-based training program for psychedelic therapy facilitators, was recently licensed by the Colorado's…
-
Medical residents and fellows at the University of Colorado School of Medicine in Aurora are looking…
-
Perspire Sauna Studio,. an infrared sauna and red-light therapy franchiser, plans to open several locations…
